Site navigation

Navigation

Ulcerative colitis (subacute manifestations) - infliximab

Infliximab for subacute manifestations of ulcerative colitis

Summary

Infliximab is not recommended for people with subacute, moderately to severely active ulcerative colitis. Subacute ulcerative colitis is defined as ulcerative colitis that would normally be managed without needing to stay in hospital overnight or having urgent surgery.


Guidance documents

Implementing this guidance

Other information

We will consult on our review plans for this guidance in February 2011

About this guidance

Technology appraisals TA140

Issued: April 2008

How this guidance was produced

See also:

Order printed copies of this guidance